Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Jerry Silver who wrote (950)	5/22/1998 11:42:00 AM
From: Sean Janzen	Read Replies (2) \| Respond to of 1501

Jerry, IZP competes with Signal to identify drug targets and drug candidates for development. The following quote comes from Signal Pharmaceuticals. "In the pharmaceutical industry, the Company competes with the research and development departments of pharmaceutical and biopharmaceutical companies and other commercial enterprises, as well as numerous academic and research institutions and governmental agencies." My guess is IZP could bring a drug to market in the next 4-7 years.